Loading
RD
Rapid Dose Therapeutics Corp Stock: price and insider trades · Canada
Rapid Dose Therapeutics Corp: what insiders have been doing
Every trade that managers of Rapid Dose Therapeutics Corp disclose to SEDI is tracked on this page. In the past year (18 October 2025 to 18 October 2026), 6 filings came from 2 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
There has been no open-market purchase by an insider of Rapid Dose Therapeutics Corp for at least a year. Between a trade and the moment it shows up on SEDI, the median delay is 51 days. That lag is the time during which only the insider knows about the trade.
Compared with its exchange (2,133 companies, median 12 filings), a count of 6 filings is below the norm.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
· cache
CA$0.10
Last declaration on 15 October 2026
Declarations6 total
17,715 shares@ CA$0.13Common SharesTSXSEDI:4791501
21,691 sharesCommon SharesTSXSEDI:4752738
Convertible Notes Secured, common shares conversion $0.17 maturity Nov 30 2025TSXSEDI:4752733
250,000 sharesWarrantsTSXSEDI:4752731
57,696 sharesCommon SharesTSXSEDI:4752730
@ €0.065Convertible NotesTSXSEDI:4752310
6 of 6 declarations
About Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics Corp is a company focused on developing drug delivery technologies. It is listed on the XTSE.
